Publications by authors named "Rachel S Simpson"

Claim this Profile
E
Evaluating the Difference in Diagnostic Accuracy on Common Dermatologic Conditions in Skin of Colour and the Impact of Artificially Processed Images.
Katrina D Cirone, Mohamed Akrout, Latif Abid Beng, Stephen Solis-Reyes, Rachel S Simpson

J Cutan Med Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: 'Dupilumab as a steroid-sparing treatment for IgG4-related disease' by Della-Torre .
Rachel S Simpson, Jason K Lee

Ann Rheum Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to : 'Interleukin-4 as a emerging target for IgG4-related disease' by Akiyama .
Rachel S Simpson, Jason K Lee

Ann Rheum Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: 'Correspondence on: 'Dupilumab as a novel steroid-sparing treatment for IgG4-related disease' by Simpson ' by Ebbo .
Rachel S Simpson, Jason K Lee

Ann Rheum Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optometry Compensation Study: Narrowing Down the Unexplained Gender Wage Gap in Optometry.
Rachel S Simpson, Breanna J Scott, Kate J Hamm, Jacquelyn M Tyra, Heather M Jackson

Optom Vis Sci· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab as a novel therapy for difficult to treat chronic spontaneous urticaria.
Jason Kihyuk Lee, Rachel S Simpson

J Allergy Clin Immunol Pract· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab as a novel steroid-sparing treatment for IgG4-related disease.
Rachel S Simpson, Stephanie Ka Ching Lau, Jason Kihyuk Lee

Ann Rheum Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab as single-dose therapy for vernal keratoconjunctivitis.
Rachel S Simpson, Jason K Lee

Ann Allergy Asthma Immunol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis